Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Directorate Change

20 Jun 2019 07:00

RNS Number : 8227C
Allied Minds PLC
20 June 2019
 

Directorate change

 

Boston, MA (20 June 2019) - Allied Minds PLC ("Allied Minds" or the "Company") today announces changes to the board of directors to align with the company's previously announced strategy and its stated cost reduction targets.

Peter Dolan and Kevin Sharer, Chairman and Senior Independent Director, respectively, will retire from the board of directors effective from the end of the Company's upcoming Annual General Meeting on 28 June 2019. Jeff Rohr and Harry Rein, both current Non-Executive Directors of Allied Minds, will assume the Chairman and Senior Independent Director roles, respectively, from this date. Following the AGM: the Company's Audit Committee will be chaired by Fritz Foley; the Nomination Committee will be chaired by Jeff Rohr; and the Remuneration Committee will be chaired by Harry Rein. Each committee will consist of 3 Non-Executive Directors. In total the board will consist of 5 directors, of which 3 will be independent Non-Executive Directors, with Co-CEOs Mike Turner and Joe Pignato serving as Executive Directors.

Jeff Rohr commented "I am looking forward to becoming Chairman of the board of Allied Minds and to continuing to work closely with my colleagues on the board for the benefit of our shareholders. Allied Minds is at an inflection point, with a new leadership team and strategy. We are narrowing our focus to a limited number of portfolio companies and aggressively controlling costs. We are excited about the portfolio and our ability to deliver returns to shareholders. In the nearer term, we are particularly optimistic about Hawkeye 360, Federated Wireless and Spin Memory. These are highly-innovative companies led by dynamic management teams. The board will do everything possible to maximize shareholder value and drive monetization of the portfolio. On behalf of the board, I extend our deep appreciation to Peter Dolan and Kevin Sharer for their leadership, dedication, and commitment to the Company for the past five years."

Peter Dolan commented "Allied Minds has a new strategy, new leadership primed to execute the strategy, and some very promising companies backed by both strategic and financial investors. The Company is on the brink of growing meaningful revenue platforms at HawkEye 360, Federated Wireless and Spin Memory. We wish the new management and the board all the success in delivering on the promise of the Allied Minds portfolio."

This announcement has been made in accordance with Listing Rule 9.6.11 R. Both Peter Dolan and Kevin Sharer will cease to be directors at the conclusion of the AGM and resolutions 6 and 10, which relate to their re-election, will be withdrawn. (Resolution 7 relating to the re-election of Ms Jill Smith as a director has also been withdrawn following the announcement on 10 June 2019). This does not affect the validity of any proxy votes already submitted.

 

ENDS

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+44 7771 872 922

IR@alliedminds.com

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

__________

 

Notes:

Following the changes described above, Allied Minds remains compliant with the provisions of the 2016 Corporate Governance Code, save as explained in the Company's 2018 Annual Report.

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology and life science sectors. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFLMPTMBBBBLL
Date   Source Headline
16th Jul 20217:00 amRNSTransaction in Own Shares
13th Jul 20217:00 amRNSTransaction in Own Shares
7th Jul 20217:00 amRNSTransaction in Own Shares
5th Jul 20217:00 amRNSTransaction in Own Shares
2nd Jul 20217:00 amRNSTransaction in Own Shares
1st Jul 20217:00 amRNSTransaction in Own Shares
30th Jun 20217:00 amRNSTransaction in Own Shares
29th Jun 20217:00 amRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in own shares
25th Jun 20217:00 amRNSTransaction in own shares
24th Jun 20217:00 amRNSTransaction in own shares
23rd Jun 20217:00 amRNSPortfolio company update and share buyback
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:36 pmRNSPrice Monitoring Extension
3rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSOcuTerra Therapeutics Series B Second Close
24th May 20214:41 pmRNSSecond Price Monitoring Extn
24th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20214:40 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20215:28 pmRNSResult of AGM
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
28th Apr 20217:00 amRNSOcuTerra Therapeutics Raises Series B Financing
15th Apr 20217:00 amRNSBlock Listing Application
13th Apr 20217:00 amRNSOrbital Sidekick Closes $16m Series A Financing
9th Apr 20217:00 amRNSCapital Markets Day
6th Apr 20217:00 amRNSNotice of AGM
1st Apr 20215:34 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSAnnual results release
29th Mar 20214:28 pmRNSHolding(s) in Company
22nd Mar 20217:00 amRNSNotice of results - update
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20219:00 amRNSNotice of Results
23rd Feb 20217:00 amRNSBridgeComm Advances Development of MOCA Technology
2nd Feb 20219:33 amRNSDirector/PDMR Shareholding
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSDirectorate Change
8th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20215:15 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSStrategic update
24th Dec 20207:00 amRNSOrbital Sidekick Series A Financing
21st Dec 20203:25 pmRNSFederated Wireless partners with TESSCO
1st Dec 20203:35 pmRNSTotal Voting Rights
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSShareholder engagement update on 2020 AGM vote

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.